Bhatia Deepit, Crowcroft Natasha, Antoni Sébastien, Danovaro-Holliday M Carolina, Bose Anindya Sekhar, Minta Anna, Masresha Balcha, Ferrari Matthew J
Pennsylvania State University, United States.
WHO-IVB, Switzerland.
Vaccine. 2025 Jul 11;60:127277. doi: 10.1016/j.vaccine.2025.127277. Epub 2025 May 27.
Measles vaccination has significantly reduced the global burden of the disease, but disparities in vaccination coverage persist. Accurate and timely estimates of subnational vaccination coverage are crucial for identifying high-risk areas and guiding targeted interventions. However, existing methods face limitations related to accuracy, timeliness, and spatial resolution. We explored the use of routinely collected case-based surveillance data to predict measles vaccination coverage at the subnational level.
The study used aggregated case data from 18 countries in the WHO African region, obtained from the WHO measles surveillance database. Three surveillance-based indicators were derived: mean age of suspected measles cases, proportion of vaccinated suspected cases, and proportion of IgM-negative suspected cases. These indicators were used to build a beta regression model with measles vaccination coverage from the Demographic and Health Surveys (DHS) as the gold standard. We compared out-of-sample predictions created using this model to withheld DHS estimates using Pearson's rho.
We found that each of the three surveillance-based indicators were more strongly correlated with DHS-based survey coverage than administrative estimates. Out-of-sample predictions achieved high correlation with DHS-based coverage, with a rho of 0.74.
The findings suggest that routinely collected measles surveillance data can effectively predict subnational measles vaccination coverage. The approach addresses limitations of existing methods by providing yearly estimates that are more accurate than administrative data and more readily available than surveys. This enables timely identification of low-coverage areas and facilitates targeted interventions.
麻疹疫苗接种已显著降低了全球该疾病的负担,但疫苗接种覆盖率仍存在差异。准确及时地估计国家以下层面的疫苗接种覆盖率对于确定高风险地区和指导有针对性的干预措施至关重要。然而,现有方法在准确性、及时性和空间分辨率方面存在局限性。我们探索了使用常规收集的基于病例的监测数据来预测国家以下层面的麻疹疫苗接种覆盖率。
该研究使用了从世界卫生组织麻疹监测数据库获取的世卫组织非洲区域18个国家的汇总病例数据。得出了三个基于监测的指标:疑似麻疹病例的平均年龄、接种疫苗的疑似病例比例以及IgM阴性疑似病例比例。这些指标被用于构建一个以人口与健康调查(DHS)中的麻疹疫苗接种覆盖率为金标准的贝塔回归模型。我们使用皮尔逊相关系数(Pearson's rho)将使用该模型创建的样本外预测与预留的DHS估计值进行比较。
我们发现,与行政估计相比,三个基于监测的指标中的每一个与基于DHS的调查覆盖率的相关性都更强。样本外预测与基于DHS的覆盖率具有高度相关性,相关系数为0.74。
研究结果表明,常规收集的麻疹监测数据可以有效预测国家以下层面的麻疹疫苗接种覆盖率。该方法通过提供比行政数据更准确且比调查更容易获得的年度估计值,解决了现有方法的局限性。这能够及时识别低覆盖率地区并促进有针对性的干预措施。